PRESS RELEASE published on 02/05/2026 at 07:30, 4 months 9 days ago Lithuania Selects Procivis for the National European Digital Identity Wallet Sandbox Lithuania selects Procivis to provide EUDI Wallet sandbox, facilitating digital identity activities and readiness for EU-wide launch. Procivis One technology ensures secure interoperability and regulatory alignment Digital Identity Sandbox Lithuania Procivis EUDI Wallet
BRIEF published on 01/02/2026 at 08:05, 5 months 12 days ago Frédéric Prince nommé PDG de Neovii Pharmaceuticals Transition Du PDG Changement De Leadership Neovii Pharmaceuticals Frédéric Prince Perte Chrétienne
BRIEF published on 01/02/2026 at 08:05, 5 months 12 days ago Frédéric Prince to Lead Neovii Pharmaceuticals as New CEO CEO Transition Leadership Change Neovii Pharmaceuticals Frédéric Prince Christian Loss
PRESS RELEASE published on 01/02/2026 at 08:00, 5 months 12 days ago CEO transition at Neovii Pharmaceuticals: Frédéric Prince to succeed Christian Loss, effective January 1st, 2026 Frédéric Prince to succeed Christian Loss as CEO of Neovii Pharmaceuticals on January 1st, 2026. Dr. Loss retires after distinguished career. Dr. Prince brings extensive experience in research & development and commercial functions CEO Transition Leadership Roles Neovii Pharmaceuticals Frédéric Prince Christian Loss
BRIEF published on 12/24/2025 at 13:03, 5 months 21 days ago DiNABIOS se félicite de l'adoption de la loi de modernisation de la FDA 3.0 Innovation Développement De Médicaments DiNABIOS Modernisation De La FDA Nouvelles Méthodologies D'approche
BRIEF published on 12/24/2025 at 13:03, 5 months 21 days ago DiNABIOS Welcomes FDA Modernization Act 3.0 Passage Innovation Drug Development FDA Modernization DiNABIOS New Approach Methodologies
PRESS RELEASE published on 12/24/2025 at 12:58, 5 months 21 days ago DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs) DiNABIOS celebrates U.S. Senate passage of FDA Modernization Act 3.0, promoting human-relevant NAMs for drug development and reducing animal testing Drug Development DiNABIOS FDA Modernization Act 3.0 NAMs Animal Testing
BRIEF published on 12/23/2025 at 14:41, 5 months 22 days ago DiNAQOR présente une plateforme révolutionnaire pour l'administration de médicaments de précision. Biotechnologie Thérapie Génique Médecine De Précision DiNAQOR Perfusion Loco-régionale
BRIEF published on 12/23/2025 at 14:41, 5 months 22 days ago DiNAQOR Introduces Breakthrough Platform for Precision Drug Delivery Biotechnology Precision Medicine Gene Therapy DiNAQOR Loco-Regional Perfusion
PRESS RELEASE published on 12/23/2025 at 14:36, 5 months 22 days ago DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development Advanced Therapies DiNAQOR Academic Partners Percutaneous Platform Organ-specific Delivery
Published on 06/13/2026 at 04:50, 2 days 1 hour ago BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 2 days 4 hours ago Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 2 days 6 hours ago BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 2 days 7 hours ago Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 2 days 14 hours ago Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders
Published on 06/15/2026 at 05:45, 15 minutes ago Un robot au volant : THINKCAR et MUCAR présentent le diagnostic par IA à plus de 200 KOL lors de l’AliExpress Brand+ Summer Party à Londres
Published on 06/15/2026 at 05:45, 15 minutes ago A Robot Sat in the Driver's Seat: THINKCAR and MUCAR Brought AI Diagnostics to 200+ KOLs at the AliExpress Brand+ Summer Party in London
Published on 06/14/2026 at 14:50, 15 hours 10 minutes ago Zug voters say yes to Metalli development plan
Published on 06/14/2026 at 13:30, 16 hours 30 minutes ago Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Published on 06/14/2026 at 10:42, 19 hours 17 minutes ago LightOn Demonstrates the Flexibility of Its OCR Model by Adapting It to Arabic Through Targeted Training.
Published on 06/12/2026 at 18:31, 2 days 11 hours ago Share retention commitments (Dutreil agreement)
Published on 06/12/2026 at 17:45, 2 days 12 hours ago Engagements de conservation d’actions (Pacte Dutreil)
Published on 06/12/2026 at 16:19, 2 days 13 hours ago SMTPC - Communiqué sur la Reconduite des mandats du Président et du Directeur général
Published on 06/12/2026 at 12:56, 2 days 17 hours ago SIEHM-Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026
Published on 06/12/2026 at 12:35, 2 days 17 hours ago SFCMC - Avis de convocation à l'Assemblée Générale Extraordinaire du 30 juin 2026